NextGen Biomed 2025, London, UK, March 12-14, 2025
Conference
Event
-
February 26, 2025
genOway's presentation on Thursday, March 13, 2025 | 4.30 p.m. GMT:
Assessment of translational tumor biology and efficacy in humanized mouse models
- Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Investigating human immune cell recruitment into tumor microenvironment in BRGSF-HIS mice
- Assessment of anti-tumoral compounds in BRGSF-HIS mice
- Use of genO-hFcγR model to investigate the Fc-mediate effector functions of therapeutic antibodies
Come visit us at Booth #22!
If you cannot meet us at the conference, reach out to our team by filling out the contact form below
NextGen Biomed 2025, London, UK, March 12-14, 2025
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Tailor-made solutions adapted to scientific questions
Robust validation data on catalog models
Comprehensive dataset package
Generated with biopharma partners and in-house
Customer care
Scientific follow-up and advice along the project
Collaborative approach for problem solving and development of innovative models
Easy and fast access to models
Breeding facilities in US and Europe
Certified health status from professional breeders